Use of ICAM-1 antibodies and antisense oligonucleotides to inhibit transmigration of neutrophils

被引:19
|
作者
Sadowska, AM [1 ]
van Overveld, FJ [1 ]
Luyten, C [1 ]
Germonpré, P [1 ]
De Backer, WA [1 ]
机构
[1] Univ Antwerp UIA, Dept Resp Med, Antwerp Metab Res Unit, B-2610 Antwerp, Belgium
关键词
antisense oligonucleotides; ICAM-1; neutrophil migration;
D O I
10.1007/s00011-003-1237-x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objective: The increase in adhesion molecule expression during the initial phase of inflammation leads to transmigration of neutrophils. Inhibition of this transmigration could decrease inflammatory response and tissue damage. Materials and methods: Uptake of fluorescein-labelled oligonucleotides.. expression of ICAM-1 and neutrophil migration were studied using the bilayer of epithelial (H292) and endothelial (ECV-304) cell lines and neutrophils from peripheral blood of healthy volunteers. Results: The inhibition of ICAM-1 expression was time dependent for both cell lines, with inhibition of more than 50% after 48 h. Antisense oligos inhibited transmigration already after 4 h of incubation (6.6 +/- 2.5% versus 18.6 +/- 2.5% inhibition, p < 0.01). Antisense was more effective in preventing fMLP-induced neutrophil migration than ICAM-1 antibodies (88 ± 3.8% versus 67 ± 7% inhibition, p = 0.02). Conclusions: Antisense oligos cause a decrease in ICAM-1 expression and inhibit transmigration of neutrophils. However the effectiveness of antisense is higher than monoclonal antibodies, neither of them is able to block the migration completely. This suggests the existence of ICAM-1 independent mechanisms that are responsible for migration.
引用
收藏
页码:143 / 149
页数:7
相关论文
共 50 条
  • [1] Use of ICAM-1 antibodies and antisense oligonucleotides to inhibit transmigration of neutrophils
    A. M. Sadowska
    F. J. van Overveld
    C. Luyten
    P. Germonpré
    W. A. De Backer
    Inflammation Research, 2004, 53 : 143 - 149
  • [2] Development of an oral formulation for ICAM-1 antisense oligonucleotides
    Stepkowski, SM
    Chen, W
    Geary, R
    Yang, ME
    Condon, T
    Stecker, K
    Bennett, CF
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 387 - 387
  • [3] Antisense ICAM-1 oligonucleotides block allograft rejection in rats
    Stepkowski, SM
    Wang, ME
    Amante, A
    Kalinin, D
    Qu, X
    Blasdel, T
    Condon, T
    Kahan, BD
    Bennett, FC
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 1285 - 1285
  • [4] Development of an oral formulation for ICAM-1 antisense oligonucleotides.
    Stepkowski, SM
    Chen, W
    Geary, R
    Wang, ME
    Condon, T
    Stecker, K
    Bennett, CF
    TRANSPLANTATION, 2000, 69 (08) : S412 - S412
  • [5] INHIBITION OF MURINE ICAM-1 AND VCAM-1 WITH ANTISENSE OLIGONUCLEOTIDES
    CONDON, TP
    BENNETT, CF
    FASEB JOURNAL, 1994, 8 (05): : A972 - A972
  • [6] In vitro and in vivo effects of cholesterol conjugated ICAM-1 antisense oligonucleotides
    Manoharan, M
    Tivel, KL
    Condon, TP
    Graham, MJ
    Bennett, CF
    Cook, PD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 245 - MEDI
  • [7] Role of the intercellular adhesion molecule-1 (ICAM-1) in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice
    Kumasaka, T
    Quinlan, WM
    Doyle, NA
    Condon, TP
    Sligh, J
    Takei, F
    Beaudet, AL
    Bennett, CF
    Doerschuk, CM
    JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (10): : 2362 - 2369
  • [8] INDUCTION OF TRANSPLANTATION TOLERANCE BY TREATMENT WITH ICAM-1 ANTISENSE OLIGONUCLEOTIDES AND ANTI-LFA-1 MONOCLONAL-ANTIBODIES
    STEPKOWSKI, SM
    TU, Y
    CONDON, TP
    BENNETT, CF
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (01) : 113 - 113
  • [9] Antisense oligonucleotides for ICAM-1 attenuate reperfusion injury and renal failure in the rat
    Haller, H
    Dragun, D
    Miethke, A
    Park, JK
    Weis, A
    Lippoldt, A
    Gross, V
    Luft, FC
    KIDNEY INTERNATIONAL, 1996, 50 (02) : 473 - 480
  • [10] Prevention of ischemia-reperfusion by antisense oligonucleotides targeted to ICAM-1 in renal transplantation
    Hourmant, M
    NEPHROLOGIE, 1999, 20 (01): : 45 - 46